192 - The Fungus Among Us

10/4/2019

3:15 PM - 4:30 PM

Room: Walter E. Washington Convention Center, 151 AB

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-385-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss diagnostic and treatment approaches to mold infections, sporotrichosis, and coccidioidomycosis
identify patient groups and risk factors for these infections
list experimental vaccine approaches for these infections

Presentations:

3:15 PM - 3:40 PM
1860 - Beyond Aspergillosis: Approaches to Complex Mold Infections
Jo-Anne H. Young, MD – University of Minnesota
3:40 PM - 4:05 PM
1861 - Coccidioidomycosis: Problems and Conundra
Neil M. Ampel, MD – University of Arizona
4:05 PM - 4:30 PM
1862 - Beyond the Cat: Sporotrichosis in Brazil
Dayvison F.S. Freitas, MD, PhD – Instituto Nacional de Infectologia Evandro Chagas / Fundação Oswaldo Cruz

Moderator(s)

Tobias Hohl, MD, PhD

Associate Attending
Memorial Sloan Kettering
New York, New York

Disclosure: Nothing to disclose
Josh Nosanchuk, MD

Senior Associate Dean; Professor
Albert Einstein College of Medicine
Bronx, NY

Disclosure: Nothing to disclose

Speaker(s)

Neil Ampel, MD

Professor Emeritus of Medicine
University of Arizona
Tucson, AZ

Disclosure: Nothing to disclose
Dayvison Freitas, MD, PhD

Researcher in Public Health (Infectious Dermatology)
Instituto Nacional de Infectologia Evandro Chagas / Fundação Oswaldo Cruz
Rio De Janeiro, Brazil

Disclosure: Nothing to disclose
Jo-Anne Young, MD

Professor
University of Minnesota
Minneapolis, MN

Disclosure: Astellas Pharma: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.
Cidara: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.
Entasis Pharmaceuticals: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.
Janssen: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.
Shire: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.
Synexis: Other Financial or Material Support, The University of Minnesota is reimbursed to enroll participants on a clinical trial with this company.